UNSPSC 51451802: Imcarbofos

This classification denotes an antiparasitic agent with the molecular formula C17H30N4O7P2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21H450VP7K, chemically known as tetraethyl (2-methoxy-1,4-phenylen)bis(3-thioureidophosphonat) but generally known as imcarbofos, which bears US NIH Compound Identifier 3038394. European Medicines Agency schedules Imcarbofos in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08140MIG.

UNSPSC 51451802 Imcarbofos, a Commodity code, shows misalignment between its nominal scope and recent state and local activity. The posted opportunities do not solicit imcarbofos—an organophosphate pesticide—but instead target naloxone, drug deactivation systems, direct-to-manufacturer prescription programs, first aid and medical supplies, and generic pharmaceuticals and OTC products. No recent solicitations procure or reference imcarbofos specifically, suggesting the code either carries inaccurate tagging in state and local procurement systems or captures minimal relevant activity.

The four recent opportunities span health agencies and municipal purchasing departments across Florida, Texas, and Minnesota, with issuing bodies including Seminole County (IFB for naloxone and deactivation systems, due July 26, 2023), Texas Health and Human Services Commission (RFI on direct-to-manufacturer prescriptions, April 2026), City of Tampa (IFB for medical and first aid supplies with a $700,000 estimated value and SLBE set-aside, due March 13, 2026), and Minnesota Department of Administration administering MMCAP (RFP for generic pharmaceuticals and OTC products, due March 26, 2026). Geographic activity concentrates in the Southeast and upper Midwest, with cooperative purchasing vehicles playing a role in multi-state procurement. If your firm pursues opportunities under this code, verify the actual commodity or service category being solicited before responding, as the code's nominal scope does not align with what state and local bodies are currently buying.